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Abstract Extracorporeal shock wave lithotripsy (ESWL) is
a non-invasive procedure that allows urinary stones to be frag-
mented using acoustic shock waves. The impact of the shock
waves causes transient stinging pain at the entry site as well as
deep visceral discomfort, requiring analgesia during the pro-
cedure. The objective of this study was to compare the clinical
eYcacy of Entonox and pethidine for pain relief during outpa-
tient ESWL. We randomized 150 outpatients undergoing
elective ESWL into three groups of 50 patients, each group
receiving inhalational Entonox, intravenous pethidine, or
inhalational compressed air during ESWL. Quantitative eval-
uation of pain was performed according to a visual analogue
scale (VAS), before and after the intervention. Analysis of
variance (ANOVA) and paired t tests were used to compare
VAS scores in the three groups, before and after the interven-
tion. Entonox and pethidine decreased the pain score signiW-
cantly, while compressed air did not. There was no signiWcant
diVerence between pain relief by Entonox and pethidine. This
study demonstrates for the Wrst time that inhalational Entonox
is an eVective analgesic regimen for ESWL. Entonox can be
regarded as an appropriate alternative to analgesics like opi-
oids in relieving pain during ESWL.
Keywords Entonox · Extracorporeal shock wave 
lithotripsy · Pain relief · Pethidine
Introduction
Since 1980, extracorporeal shock wave lithotripsy (ESWL)
has become the Wrst-line treatment for most urinary stones
in adults and children [1]. However, the vast majority of
patients do not tolerate the procedure without analgesia or
sedation. Several monitored anesthesia care techniques
have been used to provide sedation and analgesia [2–5].
Some of the analgesic drugs administered for ESWL, how-
ever, carry the risk of respiratory depression, delayed dis-
charge, and/or unplanned hospital admission [6].
Entonox is a mixture of 50% nitrous oxide and 50% oxy-
gen. Inhalation produces analgesia without loss of con-
sciousness [7]. Self-administration of Entonox as an
analgesic has been widely used for many years, particularly
in obstetric practice [8], and by paramedics for prehospital
care [9]. Entonox has a good safety record, with no serious
side eVects recorded for intermittent use [7], and is rapidly
cleared from the circulation by exhalation [10].
The aim of this study was to compare the clinical
eYcacy of inhalational Entonox and pethidine for pain
relief during outpatient ESWL.
Methods
A total of 150 patients (97 men and 53 women) with stones
located in the renal pelvicalyceal system were prospec-
tively randomized to receive Entonox (preWxed equimolar
nitrous oxide and oxygen mixture), pethidine, or com-
pressed air for sedoanalgesia during lithotripsy with a third
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generation electromagnetic lithotripter (Dornier Compact
Delta magneto lithotripter).
After institutional review board approval, written
informed consent was obtained during the anesthesia con-
sultation, which was performed at least 48 h before ESWL.
During this consultation, the method of pain assessment
was explained to the patients. Patients were asked to rate
their pain on a scale from 0 (no pain) to 10 (worst possible
pain).
Patients were included in the study if they were older
than 15 years of age, had pelvicalyceal stones, and under-
stood the pain scoring. Patients were excluded from the
trial if they had any of the following: (1) serum
creatinine > 200 mol/l; (2) history of chronic use of anal-
gesics and/or sedatives; (3) allergy to any of the study med-
ications; or (4) history of middle ear surgery within the
previous month.
Just before entering the lithotripsy room, the patients
were randomly assigned to one of the three treatment
groups (Entonox, pethidine, 1 mg/kg intravenously over
10 min, or compressed air, each to be provided if the
patient asked for pain relief during ESWL) by opening a
sealed envelope. All patients were assessed by a single phy-
sician who was blinded to the patient group assignment. All
patients received no premedication and they were told not
to eat or drink for at least 4 h prior to the procedure.
The control group received compressed air, followed by
Entonox gas if pain relief was considered inadequate by the
patient.
Pain was assessed before and 2 min after receiving pain
medication by using a visual analogue scale (VAS) with
two anchor points, zero denoting no pain and ten for the
worst pain the patient had ever experienced.
Statistical analysis
Data are expressed as mean (§SD) and numbers (percent-
ages). The paired t test was used to analyze VAS score
before and after medication. Comparison of means (VAS
decrease) in the three groups was performed using one-way
ANOVA. Comparison of percentages was performed using
Chi-square analysis.
All statistical analyses were performed using SPSS®
software, version 9.0, for Windows. Results throughout the
text and tables are presented as mean § SD unless other-
wise speciWed, and statistical signiWcance was deWned as
P <0 . 0 5 .
Results
The three study groups were comparable with respect to
demographic data, history of urinary calculi and ESWL,
and location of calculi. There were no statistically signiW-
cant diVerences between the three groups (Table 1). All
patients in the three groups required analgesia. Rescue
medication in the form of pethidine was administered in
only one case in the Entonox group after recording VAS
scores because the analgesia was inadequate.
No ESWL procedure had to be prematurely terminated
because of inadequate analgesia. A patient in the Entonox
group had mild nausea that subsided spontaneously. The
other patients did not develop any complications.
Mean § SD of VAS scores before and after intervention
are shown in Table 2. Statistical analysis showed signiW-
cant decrease (Table 2) in pain severity in patients receiv-
ing Entonox or pethidine. In contrast, patients receiving
compressed air had no such change.
While VAS scores after receiving either Entonox or peth-
idine were signiWcantly diVerent from those in the control
group (P = 0.001) after receiving compressed air, statistical
comparison showed no signiWcant diVerence between post-
Entonox or post-pethidine VAS scores (P = 0.5), suggesting
that inhalational Entonox may be as eVective as intravenous
pethidine in alleviating ESWL-associated pain.
No signiWcant diVerence was found in VAS scores of
male and female patients in each group (Fig. 1).
Discussion
Extracorporeal shock wave lithotripsy (ESWL) has become
a valuable asset to the urologist and greatly beneWts stone
Table 1 Demographic data and ESWL variables in three diVerent
groups
Data are expressed as mean § SD, numbers (n), or percentages (%)
Groups Entonox Pethidine Control
Age (years) 43.76 § 11.89 45 § 13.46 43.9 § 14.21
Weight (kg) 75 § 27 8 § 37 9 § 2
Height (cm) 165 § 10 167 § 12 164 § 8
Gender (M/F) (n) 30/20 34/16 33/17
Stone location (%)
Renal 80 78 84
Ureteral 20 20 15
Both 0 2 1
Number of shocks 
delivered
2,010 § 320 2,000 § 560 2,500 § 450
Maximum voltage 
(kV) used
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patients. In a short period of time, ESWL has completely
changed the management of urinary stone disease and has
almost entirely supplanted open surgical and most endouro-
logic approaches [11]. Today, third-generation mobile elec-
tromagnetic lithotripters yield an average of 80% stone-free
rate for kidney and ureteral calculi [12].
As ESWL is frequently carried out on an outpatient
basis, it is crucial to provide adequate analgesia with mini-
mal adverse eVects [13].
Chaussy and ThuroV [14] demonstrated that analgesia
requirements in ESWL depend on lithotripter, stone loca-
tion, age, gender, and number of shock waves. The patho-
genesis of pain in ESWL is still not clearly known.
Whether it is due to cutaneous or deep visceral aVerent
stimulation is debatable [15]. The pain is presumably due to
cavitation-mediated stimulation of nerve Wbers. The inten-
sity of pain perceived during ESWL depends on the energy
level of shock waves passing through the tissues [16].
Although the development of new generation lithotripters
has decreased pain during ESWL, some form of sedation
and anesthesia may still be required to provide adequate
patient comfort and eVective treatment [15].
Any technique for alleviating ESWL-associated discom-
fort/anxiety should ideally be reliable in its eVect, of rapid
onset and short duration of action, free of adverse events,
cost-eVective, and easily administered [17].
Opioids are the most commonly used analgesics during
ESWL [18]. Despite their eVectiveness, their use may be
complicated by central nervous system (CNS) or respira-
tory depression, circulatory failure, or gastrointestinal prob-
lems [19].
Several studies have compared diVerent local and sys-
temic analgesia regimens for pain relief during ESWL, but
this, to our knowledge, is the Wrst randomized clinical trial
to evaluate the eYcacy of Entonox in the treatment of
ESWL-associated pain.
Nitrous oxide has been used for pain relief during child-
birth since the 1930s and was initially delivered at a con-
centration of 50% in air, producing an eVective analgesic
mixture. In 1961, Mike Tunstall premixed 50% nitrous
oxide with oxygen, and called it Entonox, which was
stored as a compressed gas mixture in cylinders. Since
then, the convenience of Entonox has made it a successful
and popular analgesic for labour [20]. Entonox has also
Table 2 Mean § SD of VAS scores and P-value of comparing scores before and after Entonox, pethidine, and compressed air administration in
diVerent groups
In control group, after testing with compressed air, we used Entonox. As can be seen in this group, like Entonox group, VAS score decreased
signiWcantly
VAS scores Entonox Pethidine Compressed air Entonox in the 
compressed air group
Before administration 5.76 § 1.92 6.04 § 1.54 3.6 § 1.1 4.96 § 1.42
After administration 3.73 § 2.13 4.11 § 1.69 3.48 § 1.3 3.8 § 1.74
P-value 0.001 0.001 0.426 0.001
Fig. 1 VAS scores in diVerent 
groups before and after adminis-
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proved eVective in providing pain relief in other specialties
[21, 22].
Our randomized clinical trial demonstrated that Entonox
and pethidine were equally eVective in providing analgesia
during ESWL and that they were superior to compressed
air. Entonox fulWlls many of the criteria for an ideal analge-
sic during ESWL [17] and, compared to intravenously
administered pethidine, provided comparable analgesia
with less CNS, circulatory, and respiratory depression or
nausea and vomiting.
Entonox provides rapid and eVective analgesia without
heavy sedation and leads to adequate patient relaxation and
cooperation. The eVect of Entonox was of short duration,
allowing the patients to leave the ESWL unit without the
need for a long recovery period [23]. Entonox appeared to
be associated with few, minor, and short-lived adverse
eVects such as nausea and vomiting, dizziness, dry mouth
(breathing dry gas), buzzing in the ears, and rarely, pins and
needles or numbness, dreams or drowsiness, ranging from 0
to 30% [24]. Nitrous oxide–oxygen inhalation may thus
provide a valuable alternative to conventional analgesia
regimens during ESWL.
In addition to short-acting parenteral sedative narcotics,
e.g., alfentanil, midazolam, and propofol, topical agents
such as EMLA cream, lidocaine, prilocaine and piroxicam
have been used to minimize pain during SWL [25]. Further
studies are, therefore, warranted to compare the eYcacy
and safety of Entonox with those of other analgesic regi-
mens.
Conclusions
Entonox can provide easy, rapid, and adequate pain relief
for patients undergoing ESWL, and is associated with few
and minimal side eVects.
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